Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 7,702 followers.

RT @StrippoliSabino: Beyond clinical trials: cemiplimab in frail, elderly, and immunosuppressed patients, and looking for biomarkers able t…

RT @StrippoliSabino: Beyond clinical trials: cemiplimab in frail, elderly, and immunosuppressed patients, and looking for biomarkers able t…

RT @StrippoliSabino: Beyond clinical trials: cemiplimab in frail, elderly, and immunosuppressed patients, and looking for biomarkers able t…

Beyond clinical trials: cemiplimab in frail, elderly, and immunosuppressed patients, and looking for biomarkers able to predict response

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.